πΒ New Drugs and Clinical Trials Rules, 2019 | With Allied Laws | Rajan Nijhawan | ILBCO INDIA
New Drugs and Clinical Trials Rules, 2019 | With Allied Laws by Rajan Nijhawan, published by ILBCO INDIA, is a specialized legal and regulatory reference covering the New Drugs and Clinical Trials Rules, 2019 (NDCT Rules) along with relevant allied laws.
The book is useful for understanding the regulatory framework governing new drug approvals, clinical trials, investigational new drugs, ethics committees, clinical research, bioavailability and bioequivalence studies, import and manufacture of new drugs, compensation and regulatory compliance.
The New Drugs and Clinical Trials Rules, 2019 were notified under the Drugs and Cosmetics Act, 1940 and provide the regulatory framework for important aspects of new-drug development and clinical research in India.Β
β Book Details
π’ Publisher: ILBCO INDIA
βοΈ Author: Rajan Nijhawan
π Title: New Drugs and Clinical Trials Rules, 2019 | With Allied Laws
π Language: English
π Category: Drug Laws | Clinical Trials | Pharmaceutical Law | Health Law | Medical Research Law | Regulatory Law
π― Suitable For: Law Students | Pharmaceutical Professionals | Clinical Research Professionals | Advocates | Legal Researchers | Compliance Professionals | Healthcare Professionals | Regulatory Affairs Professionals
π Why This Book is Important
The New Drugs and Clinical Trials Rules, 2019 establish an important regulatory framework for new drugs and clinical research in India. The Rules are made under the Drugs and Cosmetics Act, 1940.Β
This book helps readers understand important areas such as:
βοΈ New Drug Approval
βοΈ Clinical Trials
βοΈ Investigational New Drugs
βοΈ Ethics Committees
βοΈ Bioavailability & Bioequivalence Studies
βοΈ Import & Manufacture of New Drugs
βοΈ Regulatory Permissions
βοΈ Clinical Trial Compliance
βοΈ Allied Drug Laws
π Drug Development β Regulatory Approval β Clinical Trial β Safety β Compliance
π 1. New Drugs and Clinical Trials Rules, 2019
The NDCT Rules provide the regulatory framework for new drugs and clinical trials in India.
Readers can understand:
βοΈ Scope of the Rules
βοΈ Definitions
βοΈ Applicability
βοΈ Regulatory Authorities
βοΈ Approval Procedures
βοΈ Compliance Requirements
π Rules β Applicability β Approval β Regulation β Compliance
π§ͺ 2. New Drug Approval
New drug development requires regulatory review and approval before specified activities can proceed.
Students and professionals can study:
βοΈ New Drug Applications
βοΈ Regulatory Approval
βοΈ Safety Requirements
βοΈ Efficacy Requirements
βοΈ Quality Considerations
βοΈ Regulatory Assessment
The CDSCO's current regulatory framework specifically includes processing applications for new drug approval under the NDCT framework.Β
π Application β Evaluation β Safety & Efficacy β Approval
π¬ 3. Clinical Trials
Clinical trials are a major component of the Rules.
Readers can understand:
βοΈ Clinical Trial Permission
βοΈ Trial Phases
βοΈ Regulatory Approval
βοΈ Trial Conduct
βοΈ Safety Monitoring
βοΈ Trial Documentation
βοΈ Regulatory Compliance
π Protocol β Approval β Trial β Monitoring β Reporting
𧬠4. Investigational New Drugs
Investigational New Drugs are an important area of pharmaceutical regulatory law.
The CDSCO's Investigational New Drug division handles applications relating to clinical trials and import or manufacture of investigational new drugs under the NDCT Rules.Β
Important areas include:
βοΈ Investigational New Drug
βοΈ Clinical Trial Application
βοΈ Regulatory Permission
βοΈ Safety Assessment
βοΈ Drug Development
π Investigational Drug β Application β Regulatory Review β Clinical Trial
π§ͺ 5. Bioavailability & Bioequivalence Studies
Bioavailability and bioequivalence studies form part of the regulatory framework covered by the NDCT Rules.
Students can understand:
βοΈ Bioavailability Studies
βοΈ Bioequivalence Studies
βοΈ Study Approval
βοΈ Regulatory Requirements
βοΈ Compliance
π Drug Product β Study β Evaluation β Regulatory Assessment
ποΈ 6. Ethics Committee
Ethics Committees play an important role in protecting the rights, safety and well-being of participants involved in clinical research.
The CDSCO maintains specific regulatory material concerning Ethics Committees for clinical trials and bioavailability/bioequivalence studies under the NDCT framework.Β
Readers can study:
βοΈ Ethics Committee
βοΈ Registration
βοΈ Review
βοΈ Ethical Oversight
βοΈ Clinical Trial Monitoring
βοΈ Participant Protection
π Clinical Trial β Ethics Review β Participant Protection β Compliance
π₯ 7. Protection of Clinical Trial Participants
Clinical research requires appropriate safeguards for participants.
Important areas include:
βοΈ Participant Safety
βοΈ Informed Consent
βοΈ Ethical Review
βοΈ Adverse Events
βοΈ Compensation Framework
βοΈ Regulatory Oversight
π Participant β Consent β Safety β Monitoring β Protection
β οΈ 8. Safety Monitoring
Safety monitoring is an important component of clinical research regulation.
Professionals can understand:
βοΈ Adverse Events
βοΈ Serious Adverse Events
βοΈ Safety Reporting
βοΈ Clinical Monitoring
βοΈ Regulatory Communication
βοΈ Pharmacovigilance-Related Requirements
π Trial β Adverse Event β Reporting β Assessment β Regulatory Action
π 9. Regulatory Applications & Permissions
The NDCT framework provides various regulatory pathways and forms for applications connected with clinical trials and new drugs.
Readers can understand:
βοΈ Regulatory Applications
βοΈ Permission Procedures
βοΈ Required Documents
βοΈ Forms
βοΈ Regulatory Authorities
βοΈ Approval Process
π Application β Documents β Review β Permission
π 10. Import & Manufacture of New Drugs
The regulatory framework also deals with activities relating to the import and manufacture of new drugs.
The CDSCO identifies processes for applications relating to permission for import or manufacture of new drugs for sale or distribution under the NDCT Rules.Β
Important areas include:
βοΈ Import Permission
βοΈ Manufacturing Permission
βοΈ Regulatory Approval
βοΈ Quality Requirements
βοΈ Compliance
π Application β Regulatory Approval β Import/Manufacture β Compliance
π§ͺ 11. Clinical Research Organisation
Clinical Research Organisations are an important part of the clinical research ecosystem.
The CDSCO's NDCT regulatory materials include provisions concerning registration of Clinical Research Organisations (CROs).Β
Readers can understand:
βοΈ Clinical Research Organisations
βοΈ Registration
βοΈ Regulatory Requirements
βοΈ Clinical Trial Management
βοΈ Compliance
π CRO β Registration β Trial Management β Regulatory Compliance
π 12. Allied Laws
The book also includes allied laws, making it useful as a broader legal reference for pharmaceutical and clinical research regulation.
Readers can connect the NDCT Rules with:
βοΈ Drugs & Cosmetics Law
βοΈ Pharmaceutical Regulation
βοΈ Clinical Research Regulation
βοΈ Health Law
βοΈ Regulatory Compliance
π Primary Rules β Allied Laws β Regulatory Framework β Compliance
βοΈ 13. Regulatory Authorities
The implementation of drug and clinical trial regulations involves regulatory authorities and specialised bodies.
Students can understand:
βοΈ Central Licensing Authority
βοΈ CDSCO
βοΈ Regulatory Review
βοΈ Expert Committees
βοΈ Ethics Committees
βοΈ Regulatory Decision-Making
π Authority β Application β Review β Decision β Compliance
π 14. Regulatory Compliance
Pharmaceutical and clinical research organisations need to maintain compliance with applicable regulatory requirements.
The book can help readers understand:
βοΈ Regulatory Obligations
βοΈ Documentation
βοΈ Approvals
βοΈ Reporting
βοΈ Monitoring
βοΈ Compliance Procedures
π Regulation β Documentation β Monitoring β Reporting β Compliance
π§ 15. Drug Development & Regulatory Framework
The NDCT Rules can be understood as part of the broader drug-development lifecycle.
A simplified framework is:
Research β New Drug β Clinical Trial β Regulatory Review β Approval β Manufacture/Import β Monitoring
This makes the book useful for readers seeking a structured understanding of pharmaceutical regulatory law.
π 16. Important Study Areas
Students and professionals should focus on:
βοΈ New Drugs
βοΈ Clinical Trials
βοΈ Investigational New Drugs
βοΈ Ethics Committees
βοΈ Bioavailability
βοΈ Bioequivalence
βοΈ Clinical Trial Permissions
βοΈ Import & Manufacture
βοΈ Regulatory Applications
βοΈ Participant Safety
βοΈ Adverse Events
βοΈ Allied Laws
π New Drug β Trial β Ethics β Safety β Approval β Compliance
π 17. Useful for Law Students
This book can be useful for students studying specialised areas of law such as:
βοΈ Health Law
π Pharmaceutical Law
π§ͺ Medical Research Law
π Regulatory Law
ποΈ Administrative Law
π LLB / LLM Courses
π¨βοΈ 18. Useful for Pharmaceutical & Clinical Research Professionals
The book can also serve as a legal reference for professionals working in:
π Pharmaceutical Companies
π§ͺ Clinical Research Organisations
π¬ Clinical Research
π’ Regulatory Affairs
π Compliance
βοΈ Healthcare & Drug Regulation
π₯ 19. Why This Book is Recommended
βοΈ New Drugs and Clinical Trials Rules, 2019
βοΈ Written by Rajan Nijhawan
βοΈ Published by ILBCO INDIA
βοΈ Includes Allied Laws
βοΈ New Drug Approval
βοΈ Clinical Trials
βοΈ Investigational New Drugs
βοΈ Ethics Committees
βοΈ Bioavailability & Bioequivalence
βοΈ Regulatory Permissions
βοΈ Import & Manufacture
βοΈ Clinical Research Regulation
βοΈ Pharmaceutical Compliance
π― 20. How to Use This Book Effectively
π Step 1
Understand the Drugs and Cosmetics Act, 1940 framework.
π Step 2
Study the definition and regulatory treatment of new drugs.
π§ͺ Step 3
Understand the clinical trial approval and regulatory process.
ποΈ Step 4
Study the role of Ethics Committees and regulatory authorities.
β οΈ Step 5
Focus on participant safety, adverse events and reporting requirements.
π Step 6
Use the allied laws section to connect the NDCT Rules with the broader pharmaceutical regulatory framework.
π Act β Rules β Application β Trial β Ethics β Safety β Approval β Compliance
β Why This Book is Recommended
βοΈ New Drugs and Clinical Trials Rules, 2019
βοΈ Author: Rajan Nijhawan
βοΈ Publisher: ILBCO INDIA
βοΈ Includes Allied Laws
βοΈ New Drug Regulation
βοΈ Clinical Trial Regulation
βοΈ Investigational New Drugs
βοΈ Ethics Committee
βοΈ Bioavailability & Bioequivalence
βοΈ Regulatory Approval
βοΈ Import & Manufacture
βοΈ Pharmaceutical Law
βοΈ Clinical Research Law
βοΈ Regulatory Compliance
π― Final Verdict
New Drugs and Clinical Trials Rules, 2019 | With Allied Laws by Rajan Nijhawan, published by ILBCO INDIA, is a specialised legal reference for understanding India's regulatory framework relating to new drugs and clinical trials.
The NDCT Rules were made under the Drugs and Cosmetics Act, 1940 and cover important regulatory areas including new drug approvals, clinical trials, investigational new drugs, bioavailability and bioequivalence studies, Ethics Committees and related regulatory procedures.Β
The book can be useful forΒ law students, pharmaceutical professionals, clinical research professionals, regulatory affairs teams, compliance professionals, advocates and legal researchers who need a focused reference on drug and clinical-trial regulation.
βοΈ Rajan Nijhawan
βοΈ ILBCO INDIA
βοΈ New Drugs and Clinical Trials Rules, 2019
βοΈ Allied Laws
βοΈ Clinical Trials
βοΈ New Drug Approval
βοΈ Investigational New Drugs
βοΈ Ethics Committees
βοΈ Bioavailability & Bioequivalence
βοΈ Pharmaceutical Law
βοΈ Clinical Research Regulation
βοΈ Regulatory Compliance
π A useful specialised reference for studying India's legal and regulatory framework for new drugs and clinical trials.
BuyΒ New Drugs and Clinical Trials Rules, 2019 | With Allied Laws by Rajan Nijhawan, published by ILBCO INDIA. Covers new drug approval, clinical trials, Ethics Committees, investigational drugs, bioavailability, bioequivalence and allied laws.
New Drugs and Clinical Trials Rules 2019 Book
New Drugs and Clinical Trials Rules Book
NDCT Rules 2019 Book
New Drugs Clinical Trials Rules India
Rajan Nijhawan NDCT Book
ILBCO India Drug Law Book
New Drug Approval Book India
Clinical Trial Law Book India
Clinical Trials Rules 2019
Pharmaceutical Law Book
Drug Regulatory Law Book India
Clinical Research Law Book
Ethics Committee Clinical Trial Book
Bioavailability Bioequivalence Rules Book
Drugs and Cosmetics Act Allied Laws
Best New Drugs and Clinical Trials Rules Book
NDCT Rules 2019 Book India
Clinical Trial Regulations India Book
New Drug Approval Law Book
Clinical Trial Law for Law Students
Pharmaceutical Regulatory Law Book India
New Drugs Rules 2019 with Allied Laws
Clinical Research Regulatory Book
Drug Laws and Clinical Trials Book
Rajan Nijhawan New Drugs Book
New Drugs and Clinical Trials Rules, 2019 With Allied Laws by Rajan Nijhawan | ILBCO INDIA
Best New Drugs and Clinical Trials Rules book for pharmaceutical law and clinical research professionals
New Drugs and Clinical Trials Rules, 2019 | With Allied Laws, by Rajan Nijhawan, published by ILBCO INDIA, provides a focused reference on new drug approval, clinical trials, investigational new drugs, Ethics Committees, bioavailability and bioequivalence studies, regulatory permissions, import and manufacture of new drugs and allied pharmaceutical laws, making it useful for law students, advocates, pharmaceutical professionals, clinical research professionals, regulatory affairs teams, compliance professionals and legal researchers.